Plaintiff Asks To Unseal Seroquel Materials For FDA

By Melissa Lipman (March 11, 2009, 12:00 AM EDT) -- A man who claims that AstraZeneca Pharmaceuticals LP's Seroquel XR caused his diabetes has asked a New Jersey judge to unseal discovery materials related to clinical trials of the drug in order to share the information with the U.S. Food and Drug Administration as it considers widening the anti-psychotic's use as an antidepressant....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!